On 15-apr-2024 a spontaneous report from the united states was received via telephone regarding a 27-year-old female consumer who used a thermacare menstrual 8hr heat wrap.On 16-apr-2024, 17-apr-2024, and 23-apr-2024 additional information was provided.Medical history included allergies to penicillin and prior use of thermacare without event.On (b)(6) 2024 the consumer topically applied a thermacare menstrual heat wrap to her underwear.Approximately one-half hours after applying the heat wrap the consumer experienced a burning sensation and stinging sensation, like her skin was ripping.When she took off the patch, she noticed a large bubble that was approximately 3 inches, the size of one of the heat cells on her lower abdomen.She clarified that the burn she had was under one heat cell and not across the entirely of the patch.On (b)(6) 2024, her pain increased, and she went to an emergency room (er).She was diagnosed with first- and second-degree burns.In the emergency room she was given ketorolac tromethamine, neosporin, and clindamycin with a prescription to continue it at home.She was advised to dress the wound with neosporin and cover with a yellow solution gauze covered with non-adherent gauze daily.Since she left the er, her pain had continued to become worse, and she had difficulty walking.The area which was red had spread and the wound turned yellow and green.On (b)(6) 2024, the consumer went to urgent care, and she was given intramuscular injection of ceftriaxone.She was told to discontinue the clindamycin and prescribed her doxycycline.A wound culture was performed, and results were expected in 5-7 days.She was recommended to continue to apply neosporin and gauze wraps and take ibuprofen for pain.The skin all around the burn still hurts and has not improved.On (b)(6) 2024, the consumer went to urgent due to fatigue and dizziness.She was diagnosed with a yeast infection due to the antibiotics after a vaginal swab culture.She was given a dose of fluconazole, clotrimazole cream, and meclizine for the dizziness.Her dizziness was improved and she experienced flatulence with use of the medication.She noted the burn was starting to scab up and was significantly better.Her pain had improved and was mild.She still walked in a way in order to protect the wound.
|
The root cause cannot be identified.The site investigated this complaint by reviewing the device history records and manufacturing controls.The review of the device history records, batch thermal records, and production controls met the product release criteria.Consumer reports a burn.The cause of the consumer a burn is inconclusive since review of records does not provide evidence to support defective product.There are pre-identified risk factors that could cause a burn listed in the hazard analysis ((b)(4)).In addition to these hazards, there are multiple risks that are outside the control of the site.These include things like age, skin condition, medical conditions, device use error and off-label use.The warning labels on our product are used to address these risks and relay the appropriate instructions for use to our customers to avoid burns, blisters and skin irritations.This is an adverse event for a burn and a risk calculation cannot be determined as there is no reasonable suggestion of a device malfunction.
|